Drugs / MNC (Mononuclear cells)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04849065 | May 2021 → May 2023 | amyotrophic lateral sclerosis | Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MNC (Mononuclear cells) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04849065 ↗ |
| Route | Intramuscular | “Intramuscular infusion of autologous BM CMN into the TA muscle of one of the lower limbs” NCT04849065 ↗ |